XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Solana Sets Oct. 21 Alpenglow Handover With 82% Staked SOL Threshold
Solana has set October 21 as the handover date for Alpenglow, its proposed consensus upgrade, with the transition contingent on support from 82% of staked SOL.
Starknet Eyes L1 Shift and Quantum Resistance by 2027
Starknet is exploring a potential transition from an Ethereum Layer 2 scaling network to an independent Layer 1 blockchain, with quantum-resistant cryptography...
EPIC and QUICK Fall After Binance Delisting Announcement
Binance announced the upcoming delistings of EPIC and QUICK, sending both tokens lower as traders responded to the loss of access on one of crypto’s largest exc...
Ripple Adds DriveWealth and Meritz as Securities-Market Partners
Ripple has added DriveWealth, a US-based brokerage infrastructure provider, and Meritz, a South Korean financial firm, as securities-market partners, extending...
XRP Whale Activity on Binance Nears August Outflow Gap
XRP whale activity on Binance is picking up, with the exchange’s outflow gap narrowing toward levels last seen in August. The shift marks a meaningful change in...
US-Listed SUI ETFs Log Five Straight Weeks of Inflows
US-listed SUI exchange-traded funds have logged net inflows for five consecutive weeks, according to reporting from CryptoPotato and CryptoRank, signaling susta...
